Science and Health News

Wireless, fully implantable device gives temporary pacing without requiring removal

Researchers from Tokyo Medical and Dental University (TMDU) have designed an artificial intelligence system that rapidly identifies stem cells for growing skin grafts

Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the metabolism of the host cell in order to gain an overall advantage. According to their report in Nature Communications*, the researchers were able to identify four substances which inhibit SARS-CoV-2 replication in the host cell: spermine and spermidine, substances naturally found in the body; MK-2206, an experimental cancer drug; and niclosamide, a tapeworm drug. Charité is currently conducting a trial to determine whether niclosamide is also effective against COVID-19 in humans.

The idea of visiting the doctor’s office with symptoms of an illness and leaving with a scientifically confirmed diagnosis is much closer to reality because of new technology developed by researchers at McMaster University.

New research has uncovered a novel trick employed by the bacterium Staphylococcus aureus to thwart the immune response, raising hopes that a vaccine that prevents deadly MRSA infections is a little closer on the horizon.

A study involving virtual rather than real patients was as effective in evaluating a medical device used  to treat  brain  aneurysms, according to new research.

By identifying one of the mechanisms regulating the virulence of Pseudomonas aeruginosa, a UNIGE team is proposing a new strategy to combat this bacterium, which is resistant to many common antibiotics.

The study, published June 22 in eLife (link is external and opens in a new window), has broader significance than confirming age-old speculation about the effects of stress on hair color